Gynecologic, Ovarian, and Cervical Cancer

GYNECOLOGIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Preclinical Work on Red Blood Cell-Based Therapies in HPV-Positive Solid Tumors Provides Rationale for Clinical Trials in Humans

A microfluidics platform for engineering activated antigen carrier immunotherapies from red blood cells showed promising preliminary results in a mouse model.
New Research Says There’s No Significant Link Between Talc and Ovarian Cancer, but Some Scientists Push Back Against the Study’s Data and Design

Some experts say the talc study’s data limitations weaken its impact in the field.
Multitumor “Exceptional Responder” Program in Australia Seeks to Gain Clinical Context

The first multitumor exceptional responder program in Australia is under way, adding to the growing worldwide effort to identify patient DNA changes and biomarkers of response.
Oncologists Debate Using Maintenance Bevacizumab in Stage IIIc Ovarian Cancer

In a recent paper published in the Journal of Clinical Oncology, the authors recommended using adjuvant and maintenance bevacizumab to treat a patient with stage IIIc ovarian cancer following an optimal (R0) resection.
Dual-Targeted CAR-T Therapies in Solid Tumors: Q&A With Dr Wayne Marasco

Dr Marasco explains that CAR-T therapies are really “cellular therapies that work by way of gene manipulation,” and describes a method through which he hopes CAR-T can produce durable, long-term treatments for solid tumors.

GYNECOLOGIC CANCER NEWS

For this randomized phase 3 study, patients were assigned to motesanib plus paclitaxel and carboplat

Higher Risk of Ovarian Clear Cell Cancer in Asian Pacific Islanders

February 14, 2020

Addition of bevacizumab to NCCN guidelines as a frontline therapy in ovarian cancer spurred more utilization of the drug than did fresh findings from clinical trials.

CMS Covers Next-Generation Sequencing for Breast and Ovarian Cancer

February 7, 2020

A retrospective study showed improved survival among patients with ovarian cancer treated with beta-

ASCO Guideline: Germline Testing Recommended for All Women Diagnosed With Epithelial Ovarian Cancer

February 4, 2020

Cervical cancer cells / Science Source

Whether HPV Vaccination Will Prevent Cervical Cancer Unclear

February 4, 2020

An analysis by members of the FDA showed that time to treatment discontinuation may be a viable end point to assess drug efficacy in the postmarketing setting.

Bevacizumab Adoption Tied to Use by Peers

January 17, 2020

Next post in Gynecologic Cancer

Ovarian Cancer Treatment Regimens